p63 Expression in Nasopharyngeal Carcinoma and Its Association with EBV Infection
Author Information
Author(s): Guo Can, Pan Zhi-Gang, Li Da-Jiang, Yun Jing-Ping, Zheng Mei-Zhen, Hu Zhe-Yu, Cheng Li-Zhen, Zeng Yi-Xin
Primary Institution: Sun Yat-sen University Cancer Center
Hypothesis
This study aimed to investigate the association between p63 expression and nasopharyngeal carcinoma (NPC).
Conclusion
The study suggests that p63 may serve as a diagnostic marker for NPC and highlights its role in the pathogenesis of the disease related to EBV.
Supporting Evidence
- p63 was expressed in 100% of nasopharyngeal carcinoma tissues.
- Strong p63 staining was associated with the differential stage of NPC.
- No pathogenic mutations were detected in the p63 gene in primary NPC tissues.
Takeaway
The study found that a protein called p63 is present in all nasopharyngeal cancer samples but not in normal tissues, which could help doctors diagnose this type of cancer.
Methodology
Immunohistochemistry was performed on tissue samples to assess p63 expression, and statistical analysis was conducted using Pearson Chi-Square Test.
Limitations
The study's sample size for certain histological subtypes was small, particularly for keratinizing squamous cell carcinoma.
Participant Demographics
Participants included patients with nasopharyngeal carcinoma from Southern China.
Statistical Information
P-Value
0.001
Statistical Significance
p = 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website